Literature DB >> 30997208

Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling.

Sook-Hee Hong1.   

Abstract

Entities:  

Year:  2019        PMID： 30997208      PMCID： PMC6424728          DOI： 10.21037/jtd.2019.01.16

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  2 in total

1.  Circ_0014235 confers Gefitinib resistance and malignant behaviors in non-small cell lung cancer resistant to Gefitinib by governing the miR-146b-5p/YAP/PD-L1 pathway.

Authors:  Rong Niu; Dong Li; Jian Chen; Wentao Zhao
Journal:  Cell Cycle       Date:  2021-12-17       Impact factor: 4.534

Review 2.  The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises.

Authors:  Ángel Ortega; Ivana Vera; Maria P Diaz; Carla Navarro; Milagros Rojas; Wheeler Torres; Heliana Parra; Juan Salazar; Juan B De Sanctis; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.